Hair growth and loss are governed by a complex cycle influenced by genetics, hormones, and overall health. Treatments target specific mechanisms within this cycle to slow loss or promote regrowth. 

The Science Behind Hair Growth

Hair growth occurs in a continuous cycle with four main phases: 

  • Anagen (Growth Phase): This is the active phase where matrix cells in the hair follicle rapidly divide to form a new hair shaft. This phase lasts an average of 2 to 7 years, and its duration is the primary determinant of hair length.
  • Catagen (Transition Phase): Lasting only a few weeks, the hair follicle shrinks, detaches from the dermal papilla (blood supply), and hair growth stops. The hair becomes a "club hair".
  • Telogen (Resting Phase): The follicle is dormant for approximately three months, holding the club hair in place.
  • Exogen (Shedding Phase): This is an extension of the telogen phase where the old hair is actively shed as new hair begins to grow beneath it, and the cycle re-enters the anagen phase.

Mechanisms of Hair Loss

Disruptions to this cycle lead to hair loss, with the most common forms being: 

  • Androgenetic Alopecia (Pattern Baldness): This is a genetic condition influenced by the hormone dihydrotestosterone (DHT), a byproduct of testosterone. DHT binds to androgen receptors in the hair follicles, causing them to shrink over time (follicular miniaturization) and shortening the anagen phase until the follicle can no longer produce healthy hair.
  • Telogen Effluvium (TE): This is temporary, diffuse hair thinning triggered by significant physical or emotional stress, hormonal changes (e.g., postpartum, menopause, thyroid issues), nutritional deficiencies, or certain medications. These stressors cause a large number of hairs to prematurely enter the telogen (resting/shedding) phase. Once the underlying cause is addressed, the hair cycle usually normalizes and hair regrows. 

Science-Based Hair Loss Treatments

  1. Treatment:-Finasteride forAndrogenetic Alopecia (men only)Mechanism of Action:-An oral medication that inhibits the type II 5-alpha reductase enzyme, reducing the conversion of testosterone to DHT. This lowers DHT levels in the scalp, preventing follicular miniaturization.
  2. Treatment:-Minoxidil for Androgenetic Alopecia (men and women), Telogen EffluviumMechanism of Action:-A topical solution (or oral form) that acts as a vasodilator, increasing blood flow to the scalp and hair follicles. It is believed to open potassium channels, prolong the anagen phase, and stimulate the production of growth factors (like VEGF).
  3. Treatment:-Low-Level Laser Therapy (LLLT) for Androgenetic AlopeciaMechanism of Action:-Uses low-intensity light to stimulate cellular function, increase blood flow, and enhance levels of anti-inflammatory cytokines and growth factors within the follicles.
  4. Treatment:-Platelet-Rich Plasma (PRP) Therapy for Androgenetic AlopeciaMechanism of Action:-Involves injecting a patient's own platelet-rich plasma into the scalp to deliver growth factors that promote cell proliferation and tissue regeneration.
  5. Treatment:-Hair Transplantation for Androgenetic AlopeciaMechanism of Action:- A surgical procedure that relocates healthy hair follicles (usually from the back of the head, which are resistant to DHT) to balding areas.Emerging therapies, such as stem cell treatments and Wnt pathway activators, show promise in research by promoting the regeneration of new hair follicles, but require more clinical trials before widespread use.

    Emerging therapies, such as stem cell treatments and Wnt pathway activators, show promise in research by promoting the regeneration of new hair follicles, but require more clinical trials before widespread use.